117 related articles for article (PubMed ID: 28385250)
1. In vitro evaluation of glycol chitosan based formulations as oral delivery systems for efflux pump inhibition.
Mandracchia D; Trapani A; Tripodo G; Perrone MG; Giammona G; Trapani G; Colabufo NA
Carbohydr Polym; 2017 Jun; 166():73-82. PubMed ID: 28385250
[TBL] [Abstract][Full Text] [Related]
2. Mucoadhesive properties and interaction with P-glycoprotein (P-gp) of thiolated-chitosans and -glycol chitosans and corresponding parent polymers: a comparative study.
Trapani A; Palazzo C; Contino M; Perrone MG; Cioffi N; Ditaranto N; Colabufo NA; Conese M; Trapani G; Puglisi G
Biomacromolecules; 2014 Mar; 15(3):882-93. PubMed ID: 24521085
[TBL] [Abstract][Full Text] [Related]
3. The application of P-gp inhibiting phospholipids as novel oral bioavailability enhancers - An in vitro and in vivo comparison.
Weinheimer M; Fricker G; Burhenne J; Mylius P; Schubert R
Eur J Pharm Sci; 2017 Oct; 108():13-22. PubMed ID: 27590127
[TBL] [Abstract][Full Text] [Related]
4. Intranasal delivery of dopamine to the striatum using glycol chitosan/sulfobutylether-β-cyclodextrin based nanoparticles.
Di Gioia S; Trapani A; Mandracchia D; De Giglio E; Cometa S; Mangini V; Arnesano F; Belgiovine G; Castellani S; Pace L; Lavecchia MA; Trapani G; Conese M; Puglisi G; Cassano T
Eur J Pharm Biopharm; 2015 Aug; 94():180-93. PubMed ID: 26032293
[TBL] [Abstract][Full Text] [Related]
5. Thiolated chitosan: development and in vitro evaluation of an oral delivery system for acyclovir.
Palmberger TF; Hombach J; Bernkop-Schnürch A
Int J Pharm; 2008 Feb; 348(1-2):54-60. PubMed ID: 17716840
[TBL] [Abstract][Full Text] [Related]
6. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan.
Föger F; Schmitz T; Bernkop-Schnürch A
Biomaterials; 2006 Aug; 27(23):4250-5. PubMed ID: 16618504
[TBL] [Abstract][Full Text] [Related]
8. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
9. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties.
Dünnhaupt S; Barthelmes J; Rahmat D; Leithner K; Thurner CC; Friedl H; Bernkop-Schnürch A
Mol Pharm; 2012 May; 9(5):1331-41. PubMed ID: 22489677
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transport of P-glycoprotein substrate saquinavir in presence of thiolated chitosan.
Föger F; Kafedjiiski K; Hoyer H; Loretz B; Bernkop-Schnürch A
J Drug Target; 2007 Feb; 15(2):132-9. PubMed ID: 17365284
[TBL] [Abstract][Full Text] [Related]
11. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
Werle M; Hoffer M
J Control Release; 2006 Mar; 111(1-2):41-6. PubMed ID: 16377016
[TBL] [Abstract][Full Text] [Related]
12. In-vitro and in-vivo cytotoxicity and efficacy evaluation of novel glycyl-glycine and alanyl-alanine conjugates of chitosan and trimethyl chitosan nano-particles as carriers for oral insulin delivery.
Jafary Omid N; Bahari Javan N; Dehpour AR; Partoazar A; Rafiee Tehrani M; Dorkoosh F
Int J Pharm; 2018 Jan; 535(1-2):293-307. PubMed ID: 29138048
[TBL] [Abstract][Full Text] [Related]
13. Mucoadhesive properties of low molecular weight chitosan- or glycol chitosan- and corresponding thiomer-coated poly(isobutylcyanoacrylate) core-shell nanoparticles.
Palazzo C; Trapani G; Ponchel G; Trapani A; Vauthier C
Eur J Pharm Biopharm; 2017 Aug; 117():315-323. PubMed ID: 28455206
[TBL] [Abstract][Full Text] [Related]
14. N-mercapto acetyl-N'-octyl-O, N″-glycol chitosan as an efficiency oral delivery system of paclitaxel.
Huo M; Fu Y; Liu Y; Chen Q; Mu Y; Zhou J; Li L; Xu W; Yin T
Carbohydr Polym; 2018 Feb; 181():477-488. PubMed ID: 29253998
[TBL] [Abstract][Full Text] [Related]
15. Thiol-reactive drug substrates of human P-glycoprotein label the same sites to activate ATPase activity in membranes or dodecyl maltoside detergent micelles.
Loo TW; Clarke DM
Biochem Biophys Res Commun; 2017 Jul; 488(4):573-577. PubMed ID: 28533092
[TBL] [Abstract][Full Text] [Related]
16. ¹⁸FDG a PET tumor diagnostic tracer is not a substrate of the ABC transporter P-glycoprotein.
Krasznai ZT; Trencsényi G; Krasznai Z; Mikecz P; Nizsalóczki E; Szalóki G; Szabó JP; Balkay L; Márián T; Goda K
Eur J Pharm Sci; 2014 Nov; 64():1-8. PubMed ID: 25149126
[TBL] [Abstract][Full Text] [Related]
17. Effects of herbal drugs in Mahuang decoction and their main components on intestinal transport characteristics of Ephedra alkaloids evaluated by a Caco-2 cell monolayer model.
Zheng M; Zhou H; Wan H; Chen YL; He Y
J Ethnopharmacol; 2015 Apr; 164():22-9. PubMed ID: 25660335
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional quercetin conjugated chitosan nano-micelles with P-gp inhibition and permeation enhancement of anticancer drug.
Mu Y; Fu Y; Li J; Yu X; Li Y; Wang Y; Wu X; Zhang K; Kong M; Feng C; Chen X
Carbohydr Polym; 2019 Jan; 203():10-18. PubMed ID: 30318192
[TBL] [Abstract][Full Text] [Related]
19. N-Deoxycholic acid-N,O-hydroxyethyl Chitosan with a Sulfhydryl Modification To Enhance the Oral Absorptive Efficiency of Paclitaxel.
Yu Y; Huo M; Fu Y; Xu W; Cai H; Yao L; Chen Q; Mu Y; Zhou J; Yin T
Mol Pharm; 2017 Dec; 14(12):4539-4550. PubMed ID: 29058910
[TBL] [Abstract][Full Text] [Related]
20. Preparation and biological activity studies of resveratrol loaded ionically cross-linked chitosan-TPP nanoparticles.
Wu J; Wang Y; Yang H; Liu X; Lu Z
Carbohydr Polym; 2017 Nov; 175():170-177. PubMed ID: 28917853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
